Progesterone for the prevention of preterm birth in women with multiple pregnancies: The AMPHIA trial

BMC Pregnancy and Childbirth

Volumn 7, Issue , 2007, Pages

  Lim, Arianne C ^a   Bloemenkamp, Kitty W M ^b   Boer, Kees ^a   Duvekot, Johannes J ^c   Erwich, Jan Jaap H M ^d   Hasaart, Tom H M ^e   Hummel, Pieter ^f   Mol, Ben W J ^g   Offermans, Jos P M ^h   van Oirschot, Charlotte M ⁱ   Santema, Job G ^j   Scheepers, Hubertina C J ^k   Schöls, Willem S ^l   Vandenbussche, Frank P H A ^b   Wouters, Maurice G A J ^m   Bruinse, Hein W ⁿ  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f Medical Centre Alkmaar   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^j MEDICAL CENTER LEEUWARDEN   (Netherlands)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l MEANDER MEDICAL CENTER   (Netherlands)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; GESTAGEN; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIRTH RATE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MATERNAL MORBIDITY; MULTIPLE PREGNANCY; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PREMATURE LABOR; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; ADULT; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HIGH RISK PREGNANCY; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYPROGESTERONES; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREGNANCY, MULTIPLE; PROGESTINS; TREATMENT OUTCOME;

EID: 34447518470     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-7-7     Document Type: Article

References (24)

1. Meis PJ Klebanoff M Thom E Dombrowski MP Sibai B Moawad AH Spong CY Hauth JC Miodovnik M Varner MW Leveno KJ Caritis SN Iams JD Wapner RJ Conway D O'Sullivan MJ Carpenter M Mercer B Ramin SM Thorp JM Peaceman AM Gabbe S Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 2003 348 2379-2385 10.1056/NEJMoa035140 12802023
2. da Fonseca EB Bittar RE Carvalho MH Zugaib M Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study Am J Obstet Gynecol 2003 188 419-424 10.1067/mob.2003.41 12592250
3. Iams JD Goldenberg RL Mercer BM Moawad A Thom E Meis PJ McNellis D Caritis SN Miodovnik M Menard MK Thurnau GR Bottoms SE Roberts JM The preterm prediction study: Recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Am J Obstet Gynecol 1998 178 1035-1040 10.1016/ S0002-9378(98)70544-7 9609580
4. Honest H Bachmann LM Coomarasamy A Gupta JK Kleijnen J Khan KS Accuracy of cervical transvaginal sonography in predicting preterm birth: A systematic review Ultrasound Obstet Gynecol 2003 22 305-322 10.1002/ uog.202 12942506
5. Bruinse HW Vissser GHA Multiples Uitgeverij Elsevier/de Tijdstroom 1997
6. Dutch National Obstetric Registration 2002 Prismant 2002
7. Dutch National Neonatal Registration 2002 Prismant 2002
8. Guinn DA Atkinson MW Sullivan L Lee M MacGregor S Parilla BV Davies J Hanlon-Lundberg K Simpson L Stone J Wing D Ogasawara K Muraskas J Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial JAMA 2001 286 1581-1587 10.1001/jama.286.13.1581 11585480
9. Keirse MJ Progestogen administration in pregnancy may prevent preterm delivery Br J Obstet Gynaecol 1990 97 149-154 2138496
10. Bamigboye AA Morris J Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes Cochrane Database Syst Rev 2003 3 CD004271 http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD004353/frame.html
11. Resseguie LJ Hick JF Bruen JA Noller KL O'Fallon WM Kurland LT Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974 Fertil Steril 1985 43 514-519 3987922
12. Yovich JL Turner SR Draper R Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects Teratology 1988 38 135-144 10.1002/tera.1420380206 3175947
13. Katz Z Lancet M Skornik J Chemke J Mogilner BM Klinberg M Teratogenicity of progestogens given during the first trimester of pregnancy Obstet Gynecol 1985 65 775-780 3158848
14. Jaffe B Harlap S Baras M Gordon L Lieblich A Magidor S Sanchez M Long-term effects of MPA on human progeny: Intellectual development Contraception 1988 37 607-619 10.1016/0010-7824(88)90007-8 2969321
15. Jaffe B Shye D Harlap S Baras M Lieblich A Aggression, physical activity levels and sex role identity in teenagers exposed in utero to MPA Contraception 1989 40 351-363 10.1016/0010-7824(89)90098-X 2527728
16. Pardthaisong T Yenchit C Gray R The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation Contraception 1992 45 313-324 10.1016/0010-7824(92)90053-V 1387602
17. Oostenbrink JB Koopmanschap MA Rutten FFH Manual for cost analysis. Methods and guidelines for economic evaluation in health care. CVZ 2002
18. Gates S Brocklehurst P How should randomised trials including multiple pregnancies be analysed? BJOG 2004 111 213-219 10.1111/ j.1471-0528.2004.00059.x 14961881
19. Beirut AU Prevention of preterm delivery in twin pregnancies by 17 Alpha-hydroxyprogesterone caproate 2006 http://clinicaltrials.gov/ct/ show/NCT00141908
20. National Institute of Child Health and Human Development (NICHD) Trial of progesterone in twins and triplets to prevent preterm birth (STTARS) 2006 http://www.clinicaltrials.gov/ct/show/NCT00099164
21. North Glasgow University Hospitals Division and Glasgow University STOPPIT: A double blind randomised placebo controlled study of progesterone for the prevention of preterm birth in twins 2006 https://www.charttrials.abdn.ac.uk/stoppit/
22. Group OM 17OHP for reduction of neonatal morbidity due to PTB in twin and triplet pregnancies. 2006 http://www.clinicaltrials.gov/ct/show/ NCT00163020
23. Rigshospitalet D Does progesterone prevent very preterm delivery in twin pregnancies? 2006 http://clinicaltrials.gov/ct/show/NCT00329914
24. Calgary U Vaginal progesterone versus placebo in multiple pregnancy 2006 http://www.clinicaltrials.gov/ct/show/NCT00343265